Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenocarcinoma of the Stomach 1

Interventions

Capecitabine 28 apatinib 26 Oxaliplatin 24 Cisplatin 24 tislelizumab 23 Gemcitabine 23 Irinotecan 19 Paclitaxel 18 Carboplatin 18 Docetaxel 15 Bevacizumab 15 Fluorouracil 14 Drug Therapy 13 Cyclophosphamide 11 pembrolizumab 10 camrelizumab 10 Vinorelbine 9 Radiation 9 S 1 (combination) 8 Leucovorin 8 Cetuximab 8 toripalimab 7 sintilimab 7 Rituximab 7 Erlotinib Hydrochloride 7 pyrotinib 6 Gefitinib 6 Albumin-Bound Paclitaxel 6 fludarabine 5 anlotinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × GC1118 × Clear all

NCT04077255 2022-11-30

EGFR-targeted Therapy for Gastric Cancer

National Cancer Center, Korea

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma of the Stomach

Data powered by HemOnc (CC BY 4.0) Colophon ⚡